Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/1995
10/26/1995WO1995028481A1 Conserved t-cell receptor sequences
10/26/1995WO1995028478A1 Rps2 gene and uses thereof
10/26/1995WO1995028425A1 Preventive for circulatory diseases
10/26/1995WO1995028423A1 Rps gene family, primers, probes, and detection methods
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995CA2188182A1 Conserved t-cell receptor sequences
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995CA2187779A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995CA2187771A1 Rps gene family, primers, probes, and detection methods
10/26/1995CA2186639A1 Cell-cycle regulatory proteins, and uses related thereto
10/25/1995EP0678744A2 Method for detecting urinary tumor associated antigens
10/25/1995EP0678578A2 Multiple drug resistance gene of Aureobasidium pullulans
10/25/1995EP0678524A1 Anti-human soluble fibrin antibody hybridoma, and immunoassaying method
10/25/1995EP0678523A1 Recombinant anti-hiv antibody and preparation thereof
10/25/1995EP0678522A1 Insulin analogs
10/25/1995EP0678195A1 Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0434836B1 Method for purifying tenascin
10/25/1995CN1110681A Protein and polypeptide mercapto-polyglycol (PEG) reagent
10/24/1995US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP
10/24/1995US5460963 Plants transformed with a DNA sequence from Bacillus thuringiensis lethal to Lepidoptera
10/24/1995US5460952 Gene expression system comprising the promoter region of the α-amylase genes
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460950 Expression of PACE in host cells and methods of use thereof
10/24/1995US5460947 Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
10/24/1995US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus
10/24/1995CA1337403C Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
10/21/1995CA2147110A1 Multiple drug resistance gene of aureobasidium pullulans
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027782A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027780A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027722A1 Interleukin-15
10/19/1995WO1995027509A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187173A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995CA2164723A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677583A1 Bacillus thuringiensis isolate active against dipteran pests
10/18/1995EP0677533A2 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/18/1995EP0677116A1 A process for producing immunosuppressives and a novel microbial species to be employed therein
10/18/1995EP0677115A1 Tia-1 binding proteins and isolated complementary dna encoding the same
10/18/1995EP0677114A1 Recombinant swinepox virus
10/18/1995EP0677113A1 Viral amplification of recombinant messenger rna in transgenic plants
10/18/1995EP0677109A1 Expression system for producing apolipoprotein ai-m
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677100A1 Method for production of neuroblasts
10/18/1995EP0677053A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0515415B1 Novel vaccine and method therefor
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110177A Materials and methods for immunocontraception
10/17/1995US5459251 And a polynucleotide comprising the same that is expressed or replicated in bacteria
10/17/1995US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
10/17/1995US5459128 Restenosis inhibitors
10/17/1995US5459060 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
10/17/1995US5459052 Method of producing IGF-1
10/17/1995US5459051 Genetic engineering, gene expression
10/17/1995US5459044 High affinity monoclonal antibodies to Bowman-Birk inhibitor and immunoassay methods
10/17/1995US5459043 Hybridoma CT43 producing a monoclonal antibody to a novel mucin epitope which correlates with the presence of colorectal cancer
10/17/1995US5459041 Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
10/17/1995US5459037 Electrophoresis, change in RNA expression due to drugs, physiological or pathological conditions
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995US5459031 Adjusting carbon dioxide level in cultures
10/17/1995US5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
10/17/1995CA1337346C Process for preparing 1,5-benzothiazepine derivatives
10/12/1995WO1995027075A1 Biological markers of benign prostate hyperplasia
10/12/1995WO1995027074A1 Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027060A2 Biologically active eph family ligands
10/12/1995WO1995027059A1 Afamin: a human serum albumin-like protein
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY
10/12/1995WO1995026986A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995WO1995026981A2 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
10/12/1995WO1995026978A1 Cyclic peptide and process for producing the same
10/12/1995WO1995026751A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
1 ... 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 ... 1125